NASA is joining with Baylor College of Medicine to operate a new institute charged with researching and developing innovative approaches to reduce risks to humans on long-duration exploration missions. The NASA Translational Research Institute (NTRI) will implement a “bench-to-spaceflight” model, moving results or methods from laboratory experiments or clinical trials to point-of-care astronaut health and performance applications.
Faculty member, Dr. William Kraus, has been selected as a member of the Scientific Advisory Board of the NTRI. The role of the Board will be to advise NTRI leadership on strategic direction and tactical implementation of the Institute’s programs and to make recommendations regarding new emerging technologies and proposals.
The goal of the NTRI is to produce promising new approaches, treatments, countermeasures or technologies that have practical application to spaceflight. The Institute will partner closely with the NASA’s Human Research Program to lead the effort in translating cutting edge research into strategies aimed at reducing space flight risks.